Overland Park, KS-based Dechra Veterinary Products, a leading manufacturer, distributor and marketer of veterinary pharmaceuticals announces expansion of its North American business into the Mexican Veterinary Animal Health Market. Dechra acquired 100% of the share capital of Laboratorios Brovel, S.A. de C.V., a veterinary pharmaceuticals company based in Mexico City.
Dechra Veterinary Products is the U.S. sales and marketing division of Dechra Pharmaceuticals PLC.
Brovel is a family-owned business with more than 52 years of expereince in the production and distribugtion of pharmaceutical veterinary products. It has a diverse product portfolio and will help open the Mexican animal healt market to Dechra as well as the potential to access other Latin American markets in the future. Mexico is one of the top fifteen markets for animal health globally and within that market, Brovel is one of the top twenty companies and has produced double digit growth for many years.
The initial focus following the acquisition will be to achieve registration of several existing Dechra products in Mexico.
"Following our success with expansion into the Canadian animal health market, the acquisition of Brovel will solidify our presence as a dominant animal health company in North America," said Mike Eldred, President of North American Operations. "The team at Brovel will be instrumental to expanding the Dechra portfolio of veterinary products into Mexico and serving the veterinary community there."
Terms of the acquisition were not disclosed.